Filing Details
- Accession Number:
- 0001214659-25-005527
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2025-04-07 16:39:59
- Reporting Period:
- 2025-04-03
- Filing Date:
- 2025-04-07
- Accepted Time:
- 2025-04-07 16:39:59
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 791908 | Xoma Royalty Corp | XOMA | Pharmaceutical Preparations (2834) | 522154066 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1216023 | M Joseph Limber | C/O Xoma Royalty Corporation 2200 Powell Street, Suite 310 Emeryville 94608 | No | No | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Depositary Shares - 8.375% Series B Cumulative Stock | Acquisiton | 2025-04-03 | 16,524 | $25.22 | 16,524 | No | 4 | P | Direct | |
| 8.625% Series A Cumulative Perpetual Preferred Stock | Acquisiton | 2025-04-03 | 1,411 | $25.44 | 1,411 | No | 4 | P | Direct | |
| Depositary Shares - 8.375% Series B Cumulative Stock | Acquisiton | 2025-04-04 | 3,476 | $25.25 | 20,000 | No | 4 | P | Direct | |
| 8.625% Series A Cumulative Perpetual Preferred Stock | Acquisiton | 2025-04-04 | 3,346 | $25.56 | 4,757 | No | 4 | P | Direct | |
| 8.625% Series A Cumulative Perpetual Preferred Stock | Acquisiton | 2025-04-07 | 5,243 | $25.60 | 10,000 | No | 4 | P | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct |
Reported Non-Derivative Holdings
| Sec. Name | Remaning Holdings | Nature of Ownership | Explanation |
|---|---|---|---|
| Common Stock | 6,208 | Direct |
Footnotes
- This transaction was executed in multiple trades at prices ranging from $25.19 to $25.27. The price reported above reflects the weighted average purchase price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transaction was effected.
- This transaction was executed in multiple trades at prices ranging from $25.25 to $25.30. The price reported above reflects the weighted average purchase price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transaction was effected.
- Reflects a reverse stock split of the Issuer's common stock at a ratio of 20:1 effective October 2016.
Billionaire Hedge Funds
